NCT07680270

Brief Summary

Objectives: Measure the quality of life score in the post-interventional care pathway for patients with cardiology, using the EQ-5D-5L; measure caregivers' feelings about their work using the SAPHORA-Job; testing the feasibility and understanding of the two questionnaires among patients and caregivers; building a quality of life database that can be used for clinical, organizational, and medico-economic purposes; producing initial medical resultseconomic exploratory on the relationship between quality of life and care arrangements; and develop a deployment model that can be generalized to other CHU services.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,124

participants targeted

Target at P75+ for all trials

Timeline
23mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jun 2026May 2028

Study Start

First participant enrolled

June 19, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

June 23, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 2, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2028

Last Updated

July 2, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 23, 2026

Last Update Submit

July 1, 2026

Conditions

Keywords

quality of lifeHospital work satisfaction

Outcome Measures

Primary Outcomes (2)

  • Change in EuroQol 5-Dimension 5-Level (EQ-5D-5L) Utility Index from baseline to 3 months

    Health-related quality of life assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L). Utility index values are calculated using the validated French value set. Scores generally range from values below 0 (health states worse than death) to 1 (full health), with higher scores indicating better health-related quality of life. Unit of Measure EQ-5D-5L utility index

    Baseline (pre-intervention) and 3 months after intervention

  • Healthcare professionals' job satisfaction measured by the Satisfaction des Professionnels Hospitaliers au Travail (SAPHORA-Job) questionnaire

    Healthcare professionals' job satisfaction will be assessed using the Satisfaction des Professionnels Hospitaliers au Travail (SAPHORA-Job) questionnaire. The overall SAPHORA-Job score will be calculated as the mean of completed questionnaire items and ranges from 1 to 6, with higher scores indicating greater job satisfaction. If organizational improvement actions are implemented, the questionnaire will be administered again 12 months later to assess changes over time.

    Baseline (and 12 months, when applicable)

Study Arms (1)

patients and caregivers are their own witnesses

patients and caregivers are their own witnesses

Other: quality of life questionnaire

Interventions

quality of life questionnaire (EQ5D) and shaphora job questionnaire

patients and caregivers are their own witnesses

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients treated in cardiology units A, B1 and B2 who have undergone the following procedures: pacemaker insertion (PM), defibrillator insertion (DEF), coronary angiography (FAG) or percutaneous aortic valve implantation (TAVI).

You may qualify if:

  • For patients:
  • Patients treated in cardiology units A, B1 and B2 who have undergone the following procedures: pacemaker insertion (PM), defibrillator insertion (DEF), coronary angiography (FAG) or percutaneous aortic valve implantation (TAVI).
  • Patient aged 18 or over. Patients able to complete the questionnaire on their own.
  • For caregivers:
  • \- Working in the Cardiological Intensive Care Unit (USIC), the CB1 unit or the Cardio A unit at the Clermont-Ferrand University Hospital

You may not qualify if:

  • For patients:
  • Patients who do not master or cannot read French.
  • Patients transferred to Follow-up and Rehabilitation Care (SSR)
  • Patient under judicial protection (guardianship, curatorship) or deprived of liberty.
  • For caregivers:
  • Not proficient or unable to read French.
  • The administrative agents, the stretcher-bearers, the ASH.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Clermont-Ferrand

Clermont-Ferrand, France

Location

Study Officials

  • Romain ESCHALIER

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2026

First Posted

July 2, 2026

Study Start

June 19, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

May 30, 2028

Last Updated

July 2, 2026

Record last verified: 2026-06

Locations